Needham & Company
-
After Serious Outperformace in 2013, Needham & Company Lays Out 2014's Top Stock Picks
-
Notable 52-Week Highs and Lows of the Day 08/12: (SIRI) (NPSP) (KKD) High; (VICL) (ECTY) (DNDN) Low
-
Needham & Company Lifts PT on NPS Pharmaceuticals (NPSP)
-
Unusual 11 Mid-Day Movers 10/12: (NINE) (GLUU) (NPSP) Higher; (AEZS) (OCZ) (TZOO) Lower
-
Notable Analyst Rating Changes 10/04: (EBAY) (AMD) (EIX) Upgraded; (S) (NUVA) (PCS) Downgraded
-
Needham & Company Reiterates a 'Buy' on NPS Pharmaceuticals (NPSP); Gattex AdCom Meeting Tentatively Scheduled
-
Needham & Company Maintains a 'Buy' on NPS Pharmaceuticals (NPSP); Slight Gattex Delay Risk, Other Opportunities Underappreciated
-
Needham & Company Reiterates a 'Buy' on NPS Pharmaceuticals (NPSP) After Review of Natpara Meeting
-
Needham & Company Reiterates a 'Buy' on NPS Pharmaceuticals (NPSP); Awaiting Date for Gattex FDA AdCom Meeting
-
Needham & Company Reiterates a 'Buy' on NPS Pharmaceuticals (NPSP); Gattex PDUFA Date Announced, but FDA AdCom Timing Still Unknown
-
Needham & Company Reiterates a 'Buy' on NPS Pharmaceuticals (NPSP); Shares Undervalued
-
Needham & Company Maintains a 'Buy' on NPS Pharmaceuticals (NPSP); Favorably Inclined Based on NPS558 Trial Results
-
Needham & Company Reiterates a 'Buy' on NPS Pharmaceuticals (NPSP); Positive After Conference Call on STEPS
-
Needham & Company Reiterates a 'Buy' on NPS Pharmaceuticals (NPSP); 4Q10 Review; Attractive Valuation Post-Phase 3 Gattex Results
-
Notable 52-Week Highs and Lows of the Day 01/31: XOM, DEPO, NPSP, PLL High; BGP, AIB Low
-
Needham & Company Ups Price Target NPS Pharmaceuticals (NPSP) to $15
-
Needham & Company Reiterates a 'Buy' on NPS Pharmaceuticals (NPSP); GATTEX STEPS Phase 3 Trial Enrollment Completed
-
NPS Pharma (NPSP) Prices 9M Common Offering at $5.50/Share
-
After-Hours Movers 4/15: LGF, BSX, SIMO Higher; NPSP, GOOG, AMD, HNSN Lower
-
NPS Pharma (NPSP) to Offer 7.5M in Public Offering
-
Notable Analyst Rating Changes 04/07: NOK, KEY, AIB, IRE, DRI Upgraded; LVS, NFLX, SNH Downgraded
-
NPS Pharmaceuticals Shares (NPSP) Jump As Needham Analyst Says Time For Revisit
-
Needham & Company Initiates Coverage on NPS Pharmaceuticals (NPSP) with a Buy; Underappreciated Late-Stage Pipeline

